pI: 8.6922 |
Length (AA): 142 |
MW (Da): 16346 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
69 | 132 | 4r2y (A) | 22 | 84 | 54.00 | 0.00000000023 | 0.94 | 1.0152 | 0.52 |
78 | 125 | 2l0b (A) | 40 | 84 | 31.00 | 0.28 | 0.37 | 0.565828 | -0.02 |
96 | 125 | 1iym (A) | 151 | 176 | 42.00 | 0.0036 | 0.26 | 0.339768 | 1.6 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_129026)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G05870 | anaphase-promoting complex subunit 11 |
Brugia malayi | Bm1_37620 | putative anaphase promoting complex subunit 11 |
Brugia malayi | Bm1_49060 | putative anaphase promoting complex subunit 11 |
Candida albicans | CaO19.7644 | similar to S. cerevisiae APC11 (YDL008W) anaphase promoting complex subunit |
Caenorhabditis elegans | CELE_F35G12.9 | Protein APC-11 |
Cryptosporidium hominis | Chro.10298 | hypothetical protein |
Cryptosporidium parvum | cgd1_2640 | hypothetical protein with RING-H2 like RING domain |
Dictyostelium discoideum | DDB_G0286909 | anaphase promoting complex subunit 11 |
Drosophila melanogaster | Dmel_CG34440 | lemming A |
Echinococcus granulosus | EgrG_000069420 | anaphase promoting complex subunit 11 |
Entamoeba histolytica | EHI_135100 | zinc finger domain containing protein |
Echinococcus multilocularis | EmuJ_000069420 | anaphase promoting complex subunit 11 |
Giardia lamblia | GL50803_8432 | APC11, cyclin metabolism |
Leishmania braziliensis | LbrM.34.4480 | anaphase promoting complex subunit protein, putative |
Leishmania donovani | LdBPK_354570.1 | anaphase promoting complex subunit protein, putative |
Leishmania infantum | LinJ.35.4570 | anaphase promoting complex subunit protein, putative |
Leishmania major | LmjF.35.4500 | anaphase promoting complex subunit protein, putative |
Leishmania mexicana | LmxM.34.4500 | anaphase promoting complex subunit protein, putative |
Loa Loa (eye worm) | LOAG_01568 | hypothetical protein |
Loa Loa (eye worm) | LOAG_00857 | hypothetical protein |
Mus musculus | ENSMUSG00000025135 | anaphase promoting complex subunit 11 |
Neospora caninum | NCLIV_038660 | hypothetical protein, conserved |
Oryza sativa | 4332583 | Os03g0302700 |
Oryza sativa | 9272104 | Os07g0411101 |
Onchocerca volvulus | OVOC4367 |
|
Onchocerca volvulus | OVOC864 |
|
Plasmodium berghei | PBANKA_1123400 | anaphase-promoting complex subunit 11, putative |
Plasmodium falciparum | PF3D7_0624500 | anaphase-promoting complex subunit 11, putative |
Plasmodium knowlesi | PKNH_1125700 | anaphase-promoting complex subunit 11, putative |
Plasmodium vivax | PVX_114337 | anaphase promoting complex subunit, putative |
Plasmodium yoelii | PY04444 | putative APC11 anaphase-promoting complex subunit |
Saccharomyces cerevisiae | YDL008W | anaphase promoting complex subunit 11 |
Schistosoma japonicum | Sjp_0217080 | ko:K03358 anaphase-promoting complex component APC11, putative |
Schistosoma mansoni | Smp_028430 | Anaphase promoting complex subunit 11 homolog |
Schmidtea mediterranea | mk4.000589.04 | AT07979p1 |
Schmidtea mediterranea | mk4.001942.04 | |
Trypanosoma brucei gambiense | Tbg972.9.5890 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.9.10170 | anaphase-promoting complex subunit 11 |
Trypanosoma cruzi | TcCLB.507007.45 | anaphase promoting complex subunit protein, putative |
Trypanosoma cruzi | TcCLB.509551.95 | anaphase promoting complex subunit protein, putative |
Toxoplasma gondii | TGME49_267520 | anaphase promoting complex subunit 11, putative |
Trichomonas vaginalis | TVAG_169830 | RING finger, putative |
Trichomonas vaginalis | TVAG_389590 | RING finger, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.211.1655 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.1655 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.1655 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb09.211.1655 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F35G12.9 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F35G12.9 | Caenorhabditis elegans | sterile | wormbase |
YDL008W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_267520 | Toxoplasma gondii | Essentiality uncertain | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.